ישראל - עברית - Ministry of Health

pharmalogic ltd - risperidone 4 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ישראל - עברית - Ministry of Health

abic marketing ltd - risedronic acid sodium 75 mg - tablets - risedronic acid - treatment of osteoporosis in postmenopausal women at increased risk of fractures.prevention of osteoporosis in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.

ישראל - עברית - Ministry of Health

orgenics ltd. - רופא - ראה הוראות שימוש

ישראל - עברית - Ministry of Health

aspen marketing ltd. - אחות - תחבושת לעצירת שטף דם

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 100 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ranitidine as hydrochloride - סירופ - ranitidine as hydrochloride 150 mg / 10 ml - ranitidine - ranitidine - h2 receptor antagonist. for treatment of duodenal ulcer and benign gastric ulcer, including that associated with nsaid agents. post-operative ulcer, oesophageal reflux disease and zollinger-ellison syndrome. prophylaxis of stress ulceration in seriously ill patients. before general anaesthesia in patients considered to be of risk acid aspiration (mendelson's syndrome).

ישראל - עברית - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - טבליה - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - ondansetron - for the mangement of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting in adults.

ישראל - עברית - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - טבליה - ondansetron as hydrochloride dihydrate 4 mg - ondansetron - ondansetron - management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting in adults .

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - fondaparinux sodium - תמיסה להזרקה - fondaparinux sodium 5 mg / 1 ml - fondaparinux - fondaparinux - prevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture major knee surgery or hip replacement surgery. prevention of venous thromboembolic events (vte) in adults undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications such as patients undergoing abdominal cancer surgery. prevention of venous thromboembolic events (vte) in adults medical patients who are judged to be at high risk for vte and who are immobilised due to acute illness such as cardiac insufficiency and/or acute respiratory disorders and/or acute infectious or inflammatory disease. treatment of unstable angina or non-st segment elevation myocardial infarcton (ua/nstemi) in adults for whom urgent ( < 120 mins) invasive management (pci) is not indicated . treatment of st segment elevation myocardial infarction (stemi) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.